Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study.
Molecular docking study
Oxadiazole-thiadiazole
SAR
β-Glucuronidase inhibition
Journal
Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298
Informations de publication
Date de publication:
15 07 2019
15 07 2019
Historique:
received:
09
01
2019
revised:
16
05
2019
accepted:
31
05
2019
pubmed:
15
6
2019
medline:
10
9
2020
entrez:
15
6
2019
Statut:
ppublish
Résumé
A new series of oxadiazole with thiadiazole moiety (6-27) were synthesized, characterized by different spectroscopic techniques and evaluated for β-glucuronidase inhibitory potential. Sixteen analogs such as 6, 7, 8, 9, 10, 12, 13, 14, 17, 18, 20, 23, 24, 25, 26 and 27 showed IC
Identifiants
pubmed: 31196753
pii: S0968-0896(19)30212-3
doi: 10.1016/j.bmc.2019.05.049
pii:
doi:
Substances chimiques
Glycoproteins
0
Oxadiazoles
0
beta-glucuronidase inhibitor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3145-3155Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.